Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma
- 5 December 2005
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 28 (1), 74-80
- https://doi.org/10.1002/hed.20310
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized TrialJNCI Journal of the National Cancer Institute, 2003
- Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinomaCancer, 2002
- Combined Chemoradiation Versus Radiation Therapy Alone in Locally Advanced Nasopharyngeal CarcinomaAmerican Journal of Clinical Oncology, 2002
- Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized TrialJournal of Clinical Oncology, 2002
- Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated typeAnnals of Oncology, 2002
- Undifferentiated nasopharyngeal cancer (UCNT): Current diagnostic and therapeutic aspectsInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Pancreatic Cancer: Current status and future directions in the perioperative treatment of pancreatic cancerAnnals Of Oncology, 1994
- Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: Survival after local recurrenceInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Chemotherapy with Cisplatin and Continuous Infusion of 5-Fluorouracil and Bleomycin for Recurrent and Metastatic Nasopharyngeal Carcinoma in TaiwanOncology, 1993
- Carcinoma of the nasopharynx: factors affecting prognosisInternational Journal of Radiation Oncology*Biology*Physics, 1992